文献速递主动脉疾病内脏/肾动脉与血管畸形

复杂EVAR术后肾动脉支架闭塞的血运重建及其对肾功能的影响

Revascularization of occluded renal artery stent grafts after complex endovascular aortic repair and its impact on renal function.
PubMed 文献 · J Vasc Surg · 2020-10-19

这项多中心回顾性研究分析了38例复杂EVAR术后肾动脉支架闭塞患者的血运重建,技术成功率95.7%,36.8%肾功能改善,且改善与缺血时间无关,即使缺血超过24小时或双侧闭塞仍可能获益。

要点

  • 复杂EVAR术后肾动脉支架闭塞血运重建技术成功率高(95.7%)。
  • 肾功能改善与肾缺血时间长短无关,长缺血时间仍可尝试。
  • 双侧闭塞或孤立肾患者部分可摆脱透析,应积极干预。

核心结论

  • 复杂EVAR术后肾动脉支架闭塞的血运重建安全可行,可显著改善肾功能,即使缺血时间长或双侧闭塞,只要肾实质残余灌注存在。
  • 远期通畅率支持对F/B-EVAR术后肾动脉闭塞采取积极管理。

研究设计与样本

  • 回顾性多中心研究,纳入11家三级医院2009至2019年复杂EVAR术后肾动脉支架闭塞并接受血运重建的38例患者(46条靶血管,8例双侧闭塞)。
  • 平均年龄63.5±10岁,男性占63.2%,孤立肾6例(15.8%),FEVAR 16例(42.1%),BEVAR 22例(57.9%)。

主要发现

  • 技术成功率为95.7%(44/46条靶血管)。
  • 中位肾缺血时间27.5小时(范围4-720小时,四分位距4-36小时),94.4%患者缺血≥6小时,55.6%缺血≥24小时。
  • 14例(36.8%)肾功能改善,平均GFR改善14.2±9 mL/min/1.73 m2;24例(63.2%)无改善。
  • 肾功能改善与肾缺血时间长短无关。
  • 14例双侧闭塞或孤立肾患者中,9例部分恢复且不再需要血液透析。

临床怎么用

  • 对复杂EVAR术后肾动脉支架闭塞应积极行血运重建,技术成功率高且可能改善肾功能。
  • 即使肾缺血时间超过24小时或双侧闭塞,只要肾实质有残余灌注,仍可尝试血运重建。

局限性

  • 回顾性研究设计。
  • 样本量较小(38例患者)。
  • 中位随访时间较短(11个月)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute occlusion of renal bridging stent grafts after fenestrated/branched endovascular aortic repair (F/B-EVAR) is an acknowledged complication with high morbidity that often results in chronic dialysis dependence. The feasibility and effect of timely or late (≥6 hours of ischemia) renal artery revascularization has not been adequately reported. METHODS: We performed a retrospective, multicenter study across 11 tertiary institutions of all consecutive patients who had undergone revascularization of renal artery stent graft occlusions after complex EVAR. The end points were technical success, association between ischemia time and renal function salvage, interventional complications, mortality, and mid-term outcomes. RESULTS: From 2009 to 2019, 38 patients with 46 target vessels (TVs; eight bilateral occlusions) were treated for renal artery occlusions after complex EVAR (mean age, 63.5 ± 10 years; 63.2% male). Six patients had a solitary kidney (15.8%). Of the 38 patients, 16 (42.1%) had undergone FEVAR and 22 (57.9%) had undergone BEVAR. The technical success rate was 95.7% (44 of 46 TVs). The recanalization technique used was sole aspiration thrombectomy in 5.3%, aspiration thrombectomy and stent graft relining in 52.6%, and sole stent graft relining in 36.8%. The median renal ischemia time was 27.5 hours (range, 4-720 hours; interquartile range, 4-36 hours). Most patients (94.4%) had been treated after ≥6 hours of renal ischemia time, and 55.6% had been treated after 24 hours. In 14 patients (36.8%), renal function had improved after intervention (mean glomerular filtration rate improvement, 14.2 ± 9 mL/min/1.73 m2). However, 24 patients (63.2%) showed no improvement. Improvement of renal function did not correlate with the length of renal ischemia time. Of the 14 patients with bilateral renal artery occlusion or a solitary kidney, 9 experienced partial recovery of renal function and no longer required hemodialysis. In-hospital mortality was 2.6%. The cause of renal stent graft occlusion could not be identified in 50% of the TVs (23 of 46). However, in 19 (41.3%), significant stenosis or a kink of the renal stent graft was found. The median follow-up was 11 months (interquartile range, 0-28 months). The estimated 1-year patient survival and patency rate of the renal stent grafts was 97.4% and 83.8%, respectively. CONCLUSIONS: Revascularization of occluded renal bridging stent grafts after F/B-EVAR is a safe and feasible technique and can lead to significant improvement of renal function, even after long ischemia times (>24 hours) of the renal parenchyma or bilateral occlusion, as long as residual perfusion of the renal parenchyma has been preserved. Also, the long-term patency rates justify aggressive management of renal artery occlusion after F/B-EVAR.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Konstantinou N, Kölbel T, Dias NV, et al. Revascularization of occluded renal artery stent grafts after complex endovascular aortic repair and its impact on renal function. J Vasc Surg. 2020. PMID: 33091514. doi:10.1016/j.jvs.2020.09.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。